Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) IgG Antibody, Serum

General Information

HLAB/HOL Code: COR2G
UPHSM LIS Test #: 026678
Schedule: Daily
Testing Time:
Testing Lab: LabCorp

Specimen Info
Only 1 specimen type required, unless otherwise specified

Volume: 0.5 mL
Temperature: Refrigerated
Tube Type: Serum or Plasma
Collection Info:
Minimum Volume: 0.4 mL (Note: This volume does not allow for repeat testing.)
Container: Gel-barrier tube or serum from red-top tube or serum transfer tube, or plasma from lithium heparin or EDTA tube
Collection: Standard aseptic procedures

Specimen Acceptability

Cause for Rejection:
Grossly hemolyzed or lipemic samples and samples containing particulate matter or exhibiting obvious microbial contamination.

Methods

Chemiluminescent Immunoassay (CLIA)

Clinical Utilities

Qualitative and semi-quantitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma. This assay is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. Samples should only be tested from individuals that are 15 days or more post symptom onset. IgG antibodies to SARS-CoV-2 are generally detectable in blood several days after initial infection, although the duration of time antibodies are present post-infection is not well characterized. Individuals may have detectable virus present for several weeks following seroconversion.

CPT Codes

86769

* The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding
is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

Reference Range

Non-Reactive